Translate Bio Inc. (TBIO) NASDAQ

$37.36 0 (0.00%)

Market Cap: $0

As of 09/13/21 12:00 AM EDT. Market closed.

(TBIO)

Translate Bio Inc. (TBIO) NASDAQ

$37.36 0 (0.00%)

Market Cap: $0

As of 09/13/21 12:00 AM EDT. Market closed.

Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, or to prevent infectious diseases by generating protective immunity. Translate Bio is primarily focused on applying its technology to treat pulmonary diseases with a lead pulmonary candidate being evaluated as an ... read more

Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, or to prevent infectious diseases by generating protective immunity. Translate Bio is primarily focused on applying its technology to treat pulmonary diseases with a lead pulmonary candidate being evaluated as an inhaled treatment for cystic fibrosis (CF) in a Phase 1/2 clinical trial. Additional pulmonary diseases are being evaluated in discovery-stage research programs that utilize a proprietary lung delivery platform. Translate Bio also believes its technology may apply broadly to a wide range of diseases, including diseases that affect the liver. Additionally, the platform may be applied to various classes of treatments, such as therapeutic antibodies or protein degradation. Translate Bio is also pursuing the development of mRNA vaccines for infectious diseases under a collaboration with Sanofi Pasteur. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
122
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$37.37
Previous Close
$37.36
Days Range
$37.16 - $37.64
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
75,586,714
Open
$37.37
Previous Close
$37.36
Days Range
$37.16 - $37.64
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
75,586,714

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TRANSLATE BIO INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
BAUPOST GROUP LLC/MA 10% Owner Sep 14, 2021 Option Exercise $38.00 18,044,239 685,681,082 0 Sep 16, 2021, 05:43 PM
Renaud Ronald C JR Chief Executive Officer Sep 14, 2021 Sale $38.00 409,913 15,576,694 0 Sep 14, 2021, 07:32 PM
Renaud Ronald C JR Chief Executive Officer Sep 14, 2021 Sale $38.00 503,231 19,122,778 0 Sep 14, 2021, 07:32 PM
Renaud Ronald C JR Chief Executive Officer Sep 14, 2021 Sale $38.00 40,909 1,554,542 0 Sep 14, 2021, 07:32 PM
Renaud Ronald C JR Chief Executive Officer Apr 07, 2021 Option Exercise $7.39 9,026 66,702 503,231 Sep 14, 2021, 07:31 PM
Burgess Paul D. Chief Operating Officer, CLO Sep 14, 2021 Sale $38.00 71,833 2,729,654 0 Sep 14, 2021, 07:29 PM
Hughes Owen Director Sep 14, 2021 Sale $38.00 29,860 1,134,680 0 Sep 14, 2021, 07:26 PM
FORMELA JEAN FRANCOIS Director Sep 14, 2021 Sale $38.00 2,055,063 78,092,394 0 Sep 14, 2021, 07:23 PM
Sanofi 10% Owner Sep 14, 2021 Buy $38.00 71,983,597 2,735,376,686 75,668,031 Sep 14, 2021, 09:59 AM
Renaud Ronald C JR Chief Executive Officer, Pres. Jan 14, 2021 Option Exercise $7.39 5,639 41,673 494,205 Jan 14, 2021, 07:59 PM
FORMELA JEAN FRANCOIS Director Dec 22, 2020 Sale $25.07 82,565 2,069,870 46,640 Dec 23, 2020, 06:07 PM
FORMELA JEAN FRANCOIS Director Dec 21, 2020 Sale $25.50 56,536 1,441,928 126,505 Dec 23, 2020, 06:07 PM
Renaud Ronald C JR Chief Executive Officer, Pres. Nov 16, 2020 Option Exercise $7.39 53,007 391,725 488,566 Nov 18, 2020, 07:30 PM
FORMELA JEAN FRANCOIS Director Aug 27, 2020 Sale $14.38 10,097 145,217 3,833,122 Aug 27, 2020, 08:14 PM
FORMELA JEAN FRANCOIS Director Aug 26, 2020 Sale $14.80 44,381 656,746 3,843,219 Aug 27, 2020, 08:14 PM
FORMELA JEAN FRANCOIS Director Aug 25, 2020 Sale $15.00 34,410 516,160 3,887,600 Aug 27, 2020, 08:14 PM
Shire Human Genetic Therapies, Inc. 10% Owner Jun 30, 2020 Sale $20.68 6,824,992 141,140,837 0 Jun 30, 2020, 08:24 PM
BAUPOST GROUP LLC/MA 10% Owner Jun 26, 2020 Buy $22.00 500,000 11,000,000 18,044,239 Jun 30, 2020, 05:37 PM
Shire Human Genetic Therapies, Inc. 10% Owner Jun 03, 2020 Sale $19.75 40,086 791,699 6,824,992 Jun 05, 2020, 09:52 AM
Shire Human Genetic Therapies, Inc. 10% Owner Jun 02, 2020 Sale $19.76 105,395 2,082,903 6,870,084 Jun 03, 2020, 06:08 AM
Shire Human Genetic Therapies, Inc. 10% Owner Jun 01, 2020 Sale $19.86 108,472 2,154,121 6,971,873 Jun 03, 2020, 06:08 AM
Gallagher Brian M. Jr. Director Jul 02, 2018 Buy $13.00 269,230 3,499,990 3,697,912 Jul 05, 2018, 04:30 PM
MRL Ventures Fund LLC 10% Owner Jul 02, 2018 Buy $13.00 25,000 325,000 1,873,503 Jul 03, 2018, 06:44 PM
GLAXOSMITHKLINE PLC 10% Owner Jul 02, 2018 Buy $13.00 269,230 3,499,990 3,697,912 Jul 03, 2018, 05:59 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
BAUPOST GROUP LLC/MA 10% Owner 09/14/2021 685,681,082
Renaud Ronald C JR Chief Executive Officer 09/14/2021 15,576,694
Renaud Ronald C JR Chief Executive Officer 09/14/2021 19,122,778
Renaud Ronald C JR Chief Executive Officer 09/14/2021 1,554,542
Renaud Ronald C JR Chief Executive Officer 04/07/2021 66,702
Burgess Paul D. Chief Operating Officer, CLO 09/14/2021 2,729,654
Hughes Owen Director 09/14/2021 1,134,680
FORMELA JEAN FRANCOIS Director 09/14/2021 78,092,394
Sanofi 10% Owner 09/14/2021 2,735,376,686
Renaud Ronald C JR Chief Executive Officer, Pres. 01/14/2021 41,673
FORMELA JEAN FRANCOIS Director 12/22/2020 2,069,870
FORMELA JEAN FRANCOIS Director 12/21/2020 1,441,928
Renaud Ronald C JR Chief Executive Officer, Pres. 11/16/2020 391,725
FORMELA JEAN FRANCOIS Director 08/27/2020 145,217
FORMELA JEAN FRANCOIS Director 08/26/2020 656,746
FORMELA JEAN FRANCOIS Director 08/25/2020 516,160
Shire Human Genetic Therapies, Inc. 10% Owner 06/30/2020 141,140,837
BAUPOST GROUP LLC/MA 10% Owner 06/26/2020 11,000,000
Shire Human Genetic Therapies, Inc. 10% Owner 06/03/2020 791,699
Shire Human Genetic Therapies, Inc. 10% Owner 06/02/2020 2,082,903
Shire Human Genetic Therapies, Inc. 10% Owner 06/01/2020 2,154,121
Gallagher Brian M. Jr. Director 07/02/2018 3,499,990
MRL Ventures Fund LLC 10% Owner 07/02/2018 325,000
GLAXOSMITHKLINE PLC 10% Owner 07/02/2018 3,499,990
Load More Insider Transactions